for

Microban International Launches EcoFresh Odor-Capture Technology for Active and Outdoor Lifestyles

Engineered to capture a wide spectrum of body and environmental odorants, EcoFresh delivers lasting freshness and performance for apparel, gear…

5 months ago

Inveniam and Mantra unveil Inveniam Chain: A layer 2 blockchain for private real estate assets

ABU DHABI, United Arab Emirates and DUBAI, United Arab Emirates and NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inveniam…

5 months ago

PIVOT-PO Phase 3 Data Show Tebipenem HBrs Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared…

5 months ago

BTL’s EMSCULPT NEO Used in Astronaut Training in Hungary for International Space Mission

PRAGUE, Oct. 20, 2025 /PRNewswire/ -- BTL, a global leader in medical technologies, proudly announces that its flagship device, EMSCULPT NEO,…

5 months ago

Blockchain for Good Alliance and UNDP AltFinLab Launch Blockchain Impact Forum

DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ -- The Blockchain for Good Alliance (BGA), a flagship non-profit founded by Bybit and championing…

5 months ago

Global Investors and Business Leaders Set to Convene in Bahrain for Gateway Gulf’s third edition in November

Themed "Rethinking Global Investment for New Trade Dynamics," the invitation-only forum will host 200 senior leaders, fostering dialogue that translates…

5 months ago

Frost & Sullivan Recognizes TP with the 2025 Global Outsourcing Technology Innovation Leadership for Excellence in AI Technology and Digital Transformation

TP's AI-enabled Technology Services, automation platforms and comprehensive digital business process solutions are redefining technology innovation and human-centered services across…

5 months ago

IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025

October 20, 2025 02:30 ET  | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…

5 months ago

From Economic Turbulence to a New Era of Wealth: NB HASH RWA Brings Real-World Assets On-Chain for Stable Digital Growth

London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As global markets face inflation, currency depreciation, and rising uncertainty, investors are…

5 months ago

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION Platform at the European Society of Medical Oncology Annual Congress

October 19, 2025 10:00 ET  | Source: AVACTA GROUP PLC Median progression free survival (PFS) has not been reached in…

5 months ago